GFACX | LGLQX | GFACX / LGLQX | |
Total Expense Ratio | 1.36 | 1.25 | 109% |
Annual Report Gross Expense Ratio | 1.36 | 1.25 | 109% |
Fund Existence | 24 years | 14 years | - |
Gain YTD | 12.265 | 14.956 | 82% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 325B | 7.87B | 4,130% |
Annual Yield % from dividends | 0.00 | 0.00 | - |
Returns for 1 year | 15.43 | 43.06 | 36% |
Returns for 3 years | 34.88 | 73.03 | 48% |
Returns for 5 years | 33.15 | 35.38 | 94% |
Returns for 10 years | 66.93 | 116.95 | 57% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
NUAG | 21.01 | 0.02 | +0.10% |
Nuveen Enhanced Yield US Aggt Bd ETF | |||
BMED | 24.78 | -0.03 | -0.14% |
iShares Health Innovation Active ETF | |||
FVAL | 65.38 | -0.11 | -0.17% |
Fidelity Value Factor ETF | |||
ELCV | 25.77 | -0.12 | -0.46% |
Eventide High Dividend ETF | |||
MLPB | 25.46 | -0.25 | -0.99% |
UBS ETRACS Alerian MLPInfrs ETN SerB |